Skip to main content

Education excellence
Alumni
Jobs
Events
Visit

Switch between the UK and Dubai websites.UK Dubai

Study
Research
International
Business
News
About us

News archive
radiotherapy-between-or-during-chemotherapy-cycles-reduces-risk-of-breast-cancer-recurrence-1

Radiotherapy between or during chemotherapy cycles reduces risk of breast cancer recurrence

A major UK trial led by the University has produced firm evidence that giving radiotherapy between or during chemotherapy cycles to women with early breast cancer significantly reduces the risk of the cancer recurring in the breast or chest wall. The treatment, known as synchronous chemoradiation, has minimal adverse side-effects and no detrimental effect on the patients' quality of life.

Archived

What does this mean?

Published 27 September 2011

Edgbaston Birmingham B15 2TT United Kingdom

Tel: +44 (0)121 414 3344

Instagram
Facebook
Twitter
YouTube
Weibo
WeChat

Privacy
Legal
Accessibility
Intranet
Canvas Learning Environment
Publication Scheme
Information for Applicants
Freedom of information
Charitable information
Cookies policy and settings
Website feedback
Contact us

© University of Birmingham 2023